Delivery Order SPE2DR25D2104-SPE2DR26F3TRP
- Not listed
- The Defense Logistics Agency awarded a $3,720.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 milliliters of Epidiolex 100 mg/ml solution on November 5, 2025, with completion targeted for November 28, 2025. This is a non-set-aside delivery order issued against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be performed at the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Epidiolex 100 mg/ml solution in 100 ml packs, with a ceiling value of $1,682.50 and an ultimate completion date of October 9, 2025. This competitively awarded, firm fixed-price delivery order was placed without a set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Epidiolex is an FDA-approved...
- The Defense Logistics Agency awarded a delivery order valued at $1,773.10 to AmerisourceBergen Drug Corp (Conshohocken, PA) on January 6, 2026, for the supply of Epidiolex 100 mg/ml oral solution in 100 ml packs. This is a firm fixed-price, competitively awarded delivery order with an ultimate completion date of January 28, 2026. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor for federal medical procurement needs. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,682.50 to AmerisourceBergen Drug Corp for Epidiolex 100 mg/ml solution in a 100 ml pack. The contract was competitively awarded without set-aside designation under firm fixed pricing and is scheduled for completion by September 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,349.88 delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Epidiolex 100 mg/ml solution in 60 ml packs, with completion targeted for January 22, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,349.88 to AmerisourceBergen Drug Corp for Epidiolex 100 mg/ml solution in 60 ml packs. The contract is non-competitive with a firm fixed-price structure and is scheduled for completion by February 3, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with Cencora, Inc. acting as its parent organization. This delivery order represents a task order issued against a larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,365.00 to AmerisourceBergen Drug Corp for the supply of Epidiolex 100 mg/mL solution in 100 mL packs. This firm fixed-price delivery order, awarded on August 29, 2025, is scheduled for completion by September 22, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract represents a non-set-aside competitive award, demonstrating the vendor's capability to meet federal...
- The Defense Logistics Agency awarded a delivery order valued at $8,412.50 to AmerisourceBergen Drug Corp for Epidiolex 100 mg/mL solution in 100 mL packs, with an ultimate completion date of November 28, 2025. This is a firm fixed-price delivery order issued under a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving the federal government's medical supply needs,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $20,190.00 to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Epidiolex 100 mg/mL solution in 100 mL packs. The contract is a firm fixed price delivery order with an ultimate completion date of October 20, 2025, and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,682.50 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Epidiolex 100 mg/ml solution in a 100 ml pack. This is a firm fixed price, non-set-aside contract with an ultimate completion date of October 8, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3TRPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,699.76 to AmerisourceBergen Drug Corp on January 15, 2026, for the supply of Epidiolex 100 mg/ml solution in 60 ml packs. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of February 6, 2026, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Epidiolex is an FDA-approved cannabidiol product primarily used for treating certain seizure disorders. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (formerly known as AmerisourceBergen), a major pharmaceutical distributor serving federal healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle, enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains, serving customers including the Defense Health Agency, U.S. Coast Guard, and other federal government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 1/14/26 |